Strengthening Circadian Signals

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

May 16, 2018

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Improving Cardiometabolic Outcomes in Adults
Interventions
DIETARY_SUPPLEMENT

Melatonin 1 mg

Melatonin (1mg) or placebo will be administered daily during the intervention. Melatonin capsules will be obtained from Life Extension (Ft. Lauderdale, FL). The investigational drug pharmacy (IDP) at Northwestern Memorial Hospital will encapsulate the melatonin pills so the placebo (lactose) and melatonin pills appear identical. We have worked with this IDP on other projects. The investigators on this study have experience in administering melatonin for investigational and clinical purposes.

DIETARY_SUPPLEMENT

Placebos

Melatonin (1mg) or placebo will be administered daily during the intervention. Melatonin capsules will be obtained from Life Extension (Ft. Lauderdale, FL). The investigational drug pharmacy (IDP) at Northwestern Memorial Hospital will encapsulate the melatonin pills so the placebo (lactose) and melatonin pills appear identical. We have worked with this IDP on other projects. The investigators on this study have experience in administering melatonin for investigational and clinical purposes.

OTHER

Meal Timing

Subjects are instructed to maintain an extended overnight fasting period of 12-16 hours.

OTHER

NON Meal Timing

Subjects are instructed to maintain their habitual meal timing.

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT03490864 - Strengthening Circadian Signals | Biotech Hunter | Biotech Hunter